Cigna Corporation (CI) Shares Bought by Murphy Capital Management Inc.

Murphy Capital Management Inc. boosted its position in shares of Cigna Corporation (NYSE:CI) by 3.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,595 shares of the health services provider’s stock after buying an additional 500 shares during the period. Murphy Capital Management Inc.’s holdings in Cigna Corporation were worth $2,275,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in CI. UBS Asset Management Americas Inc. increased its position in Cigna Corporation by 78.4% in the fourth quarter. UBS Asset Management Americas Inc. now owns 1,305,749 shares of the health services provider’s stock valued at $174,173,000 after buying an additional 573,696 shares during the period. Teachers Advisors LLC increased its position in Cigna Corporation by 41.8% in the fourth quarter. Teachers Advisors LLC now owns 983,915 shares of the health services provider’s stock valued at $131,244,000 after buying an additional 289,870 shares during the period. Kentucky Retirement Systems acquired a new position in Cigna Corporation during the fourth quarter valued at approximately $2,485,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in Cigna Corporation during the fourth quarter valued at approximately $1,109,000. Finally, Chevy Chase Trust Holdings Inc. increased its position in Cigna Corporation by 3.3% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 222,948 shares of the health services provider’s stock valued at $32,659,000 after buying an additional 7,057 shares during the period. 87.61% of the stock is currently owned by institutional investors and hedge funds.

Cigna Corporation (NYSE:CI) traded down 0.56% on Friday, reaching $177.03. The company’s stock had a trading volume of 1,034,361 shares. The firm has a 50-day moving average of $173.66 and a 200 day moving average of $160.28. Cigna Corporation has a 12-month low of $115.03 and a 12-month high of $181.00. The company has a market capitalization of $44.57 billion, a price-to-earnings ratio of 20.43 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last issued its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The firm had revenue of $10.32 billion for the quarter, compared to analysts’ expectations of $10.26 billion. During the same quarter last year, the firm earned $1.98 earnings per share. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, equities research analysts anticipate that Cigna Corporation will post $10.03 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.com-unik.info/2017/08/19/murphy-capital-management-inc-has-2-28-million-stake-in-cigna-corporation-ci-updated-updated-updated.html.

Several research firms recently weighed in on CI. UBS AG reiterated a “buy” rating and issued a $186.00 price target (up previously from $181.00) on shares of Cigna Corporation in a report on Monday, June 5th. Bank of America Corporation boosted their target price on shares of Cigna Corporation from $193.00 to $198.00 and gave the company a “buy” rating in a report on Friday, June 23rd. Jefferies Group LLC restated a “buy” rating and set a $183.00 target price on shares of Cigna Corporation in a report on Thursday, June 8th. ValuEngine cut shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. Finally, Citigroup Inc. upped their price target on shares of Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. Cigna Corporation currently has a consensus rating of “Buy” and a consensus target price of $180.44.

In related news, EVP Lisa R. Bacus sold 11,455 shares of the business’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $161.57, for a total value of $1,850,784.35. Following the completion of the sale, the executive vice president now directly owns 24,753 shares of the company’s stock, valued at $3,999,342.21. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Mary T. Hoeltzel sold 500 shares of the business’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $166.70, for a total value of $83,350.00. Following the completion of the sale, the vice president now directly owns 2,449 shares of the company’s stock, valued at $408,248.30. The disclosure for this sale can be found here. Insiders sold 243,463 shares of company stock worth $41,678,984 over the last three months. 1.30% of the stock is currently owned by corporate insiders.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

What are top analysts saying about Cigna Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cigna Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit